nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00478	0.257	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00467	0.251	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00464	0.249	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00453	0.243	CbGdCrCtD
Emtricitabine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00263	0.00268	CcSEcCtD
Emtricitabine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00263	0.00267	CcSEcCtD
Emtricitabine—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.00264	CcSEcCtD
Emtricitabine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00258	0.00263	CcSEcCtD
Emtricitabine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00257	0.00262	CcSEcCtD
Emtricitabine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.0026	CcSEcCtD
Emtricitabine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00259	CcSEcCtD
Emtricitabine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00254	0.00259	CcSEcCtD
Emtricitabine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00254	0.00259	CcSEcCtD
Emtricitabine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00258	CcSEcCtD
Emtricitabine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00252	0.00256	CcSEcCtD
Emtricitabine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00252	0.00256	CcSEcCtD
Emtricitabine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00251	0.00256	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.0025	0.00255	CcSEcCtD
Emtricitabine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00252	CcSEcCtD
Emtricitabine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00252	CcSEcCtD
Emtricitabine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00247	0.00252	CcSEcCtD
Emtricitabine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.00252	CcSEcCtD
Emtricitabine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00244	0.00249	CcSEcCtD
Emtricitabine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00242	0.00247	CcSEcCtD
Emtricitabine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00242	0.00247	CcSEcCtD
Emtricitabine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00242	0.00246	CcSEcCtD
Emtricitabine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00242	0.00246	CcSEcCtD
Emtricitabine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0024	0.00245	CcSEcCtD
Emtricitabine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.0024	0.00245	CcSEcCtD
Emtricitabine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.0024	0.00245	CcSEcCtD
Emtricitabine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.0024	0.00244	CcSEcCtD
Emtricitabine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00239	0.00243	CcSEcCtD
Emtricitabine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00239	0.00243	CcSEcCtD
Emtricitabine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00237	0.00241	CcSEcCtD
Emtricitabine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00235	0.0024	CcSEcCtD
Emtricitabine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00234	0.00239	CcSEcCtD
Emtricitabine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.00238	CcSEcCtD
Emtricitabine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00238	CcSEcCtD
Emtricitabine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00231	0.00236	CcSEcCtD
Emtricitabine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00231	0.00235	CcSEcCtD
Emtricitabine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00231	0.00235	CcSEcCtD
Emtricitabine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00228	0.00232	CcSEcCtD
Emtricitabine—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00227	0.00231	CcSEcCtD
Emtricitabine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00231	CcSEcCtD
Emtricitabine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.0023	CcSEcCtD
Emtricitabine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00225	0.00229	CcSEcCtD
Emtricitabine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00224	0.00229	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00224	CcSEcCtD
Emtricitabine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00218	0.00222	CcSEcCtD
Emtricitabine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00222	CcSEcCtD
Emtricitabine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00222	CcSEcCtD
Emtricitabine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00218	0.00222	CcSEcCtD
Emtricitabine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00221	CcSEcCtD
Emtricitabine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00214	0.00218	CcSEcCtD
Emtricitabine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00216	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00209	0.00213	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00208	0.00212	CcSEcCtD
Emtricitabine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.00212	CcSEcCtD
Emtricitabine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00208	0.00212	CcSEcCtD
Emtricitabine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.0021	CcSEcCtD
Emtricitabine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00204	0.00208	CcSEcCtD
Emtricitabine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00203	0.00207	CcSEcCtD
Emtricitabine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00207	CcSEcCtD
Emtricitabine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00207	CcSEcCtD
Emtricitabine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00207	CcSEcCtD
Emtricitabine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00207	CcSEcCtD
Emtricitabine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00206	CcSEcCtD
Emtricitabine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00206	CcSEcCtD
Emtricitabine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00202	0.00206	CcSEcCtD
Emtricitabine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00202	0.00206	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00206	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00206	CcSEcCtD
Emtricitabine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00202	0.00205	CcSEcCtD
Emtricitabine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00203	CcSEcCtD
Emtricitabine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00203	CcSEcCtD
Emtricitabine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00202	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00201	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00197	0.00201	CcSEcCtD
Emtricitabine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.002	CcSEcCtD
Emtricitabine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00197	CcSEcCtD
Emtricitabine—Infection—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00197	CcSEcCtD
Emtricitabine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00195	CcSEcCtD
Emtricitabine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00195	CcSEcCtD
Emtricitabine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00195	CcSEcCtD
Emtricitabine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00195	CcSEcCtD
Emtricitabine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00195	CcSEcCtD
Emtricitabine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00195	CcSEcCtD
Emtricitabine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00191	0.00194	CcSEcCtD
Emtricitabine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00193	CcSEcCtD
Emtricitabine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00189	0.00193	CcSEcCtD
Emtricitabine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00189	0.00193	CcSEcCtD
Emtricitabine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00189	0.00193	CcSEcCtD
Emtricitabine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00188	0.00192	CcSEcCtD
Emtricitabine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00191	CcSEcCtD
Emtricitabine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00187	0.0019	CcSEcCtD
Emtricitabine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00185	0.00189	CcSEcCtD
Emtricitabine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00186	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00182	0.00185	CcSEcCtD
Emtricitabine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00181	0.00184	CcSEcCtD
Emtricitabine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00184	CcSEcCtD
Emtricitabine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00182	CcSEcCtD
Emtricitabine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00178	0.00181	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00181	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00181	CcSEcCtD
Emtricitabine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Emtricitabine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Emtricitabine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00175	0.00178	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00177	CcSEcCtD
Emtricitabine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00174	0.00177	CcSEcCtD
Emtricitabine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.00177	CcSEcCtD
Emtricitabine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00176	CcSEcCtD
Emtricitabine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00175	CcSEcCtD
Emtricitabine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00175	CcSEcCtD
Emtricitabine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00175	CcSEcCtD
Emtricitabine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.00174	CcSEcCtD
Emtricitabine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00172	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00171	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00171	CcSEcCtD
Emtricitabine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00171	CcSEcCtD
Emtricitabine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00171	CcSEcCtD
Emtricitabine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00171	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00171	CcSEcCtD
Emtricitabine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00167	0.0017	CcSEcCtD
Emtricitabine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.0017	CcSEcCtD
Emtricitabine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00169	CcSEcCtD
Emtricitabine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00168	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00168	CcSEcCtD
Emtricitabine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00164	0.00168	CcSEcCtD
Emtricitabine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00167	CcSEcCtD
Emtricitabine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00166	CcSEcCtD
Emtricitabine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00166	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00162	0.00165	CcSEcCtD
Emtricitabine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00165	CcSEcCtD
Emtricitabine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00164	CcSEcCtD
Emtricitabine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00164	CcSEcCtD
Emtricitabine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00163	CcSEcCtD
Emtricitabine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0016	0.00163	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00162	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00162	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00162	CcSEcCtD
Emtricitabine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00162	CcSEcCtD
Emtricitabine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.0016	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00159	CcSEcCtD
Emtricitabine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00158	CcSEcCtD
Emtricitabine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00158	CcSEcCtD
Emtricitabine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00157	CcSEcCtD
Emtricitabine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00157	CcSEcCtD
Emtricitabine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00157	CcSEcCtD
Emtricitabine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00157	CcSEcCtD
Emtricitabine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00153	0.00156	CcSEcCtD
Emtricitabine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00155	CcSEcCtD
Emtricitabine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00155	CcSEcCtD
Emtricitabine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00152	0.00155	CcSEcCtD
Emtricitabine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00154	CcSEcCtD
Emtricitabine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00154	CcSEcCtD
Emtricitabine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00154	CcSEcCtD
Emtricitabine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00154	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00153	CcSEcCtD
Emtricitabine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00149	CcSEcCtD
Emtricitabine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00148	CcSEcCtD
Emtricitabine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00148	CcSEcCtD
Emtricitabine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00146	CcSEcCtD
Emtricitabine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00146	CcSEcCtD
Emtricitabine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00143	0.00146	CcSEcCtD
Emtricitabine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00145	CcSEcCtD
Emtricitabine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00143	CcSEcCtD
Emtricitabine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Emtricitabine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Emtricitabine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00138	0.0014	CcSEcCtD
Emtricitabine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.0014	CcSEcCtD
Emtricitabine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00138	0.0014	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00138	0.0014	CcSEcCtD
Emtricitabine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00139	CcSEcCtD
Emtricitabine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00138	CcSEcCtD
Emtricitabine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00137	CcSEcCtD
Emtricitabine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00136	CcSEcCtD
Emtricitabine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00136	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00135	CcSEcCtD
Emtricitabine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Emtricitabine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00133	CcSEcCtD
Emtricitabine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00133	CcSEcCtD
Emtricitabine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00131	CcSEcCtD
Emtricitabine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00131	CcSEcCtD
Emtricitabine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00129	CcSEcCtD
Emtricitabine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00128	CcSEcCtD
Emtricitabine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00128	CcSEcCtD
Emtricitabine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00126	CcSEcCtD
Emtricitabine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00126	CcSEcCtD
Emtricitabine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00125	CcSEcCtD
Emtricitabine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00125	CcSEcCtD
Emtricitabine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00125	CcSEcCtD
Emtricitabine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00125	CcSEcCtD
Emtricitabine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00124	CcSEcCtD
Emtricitabine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00124	CcSEcCtD
Emtricitabine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00124	CcSEcCtD
Emtricitabine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00124	CcSEcCtD
Emtricitabine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00124	CcSEcCtD
Emtricitabine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00124	CcSEcCtD
Emtricitabine—Rash—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00123	CcSEcCtD
Emtricitabine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00122	CcSEcCtD
Emtricitabine—Depression—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00122	CcSEcCtD
Emtricitabine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00122	CcSEcCtD
Emtricitabine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.0012	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00118	0.0012	CcSEcCtD
Emtricitabine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00119	CcSEcCtD
Emtricitabine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Emtricitabine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Emtricitabine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Emtricitabine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Emtricitabine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00117	CcSEcCtD
Emtricitabine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00115	CcSEcCtD
Emtricitabine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00111	CcSEcCtD
Emtricitabine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00108	CcSEcCtD
Emtricitabine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000974	0.000993	CcSEcCtD
Emtricitabine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000954	0.000972	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000947	0.000965	CcSEcCtD
Emtricitabine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000945	0.000963	CcSEcCtD
Emtricitabine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000939	0.000957	CcSEcCtD
Emtricitabine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000902	0.000919	CcSEcCtD
Emtricitabine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000868	0.000884	CcSEcCtD
Emtricitabine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000858	0.000874	CcSEcCtD
Emtricitabine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000838	0.000854	CcSEcCtD
Emtricitabine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000799	0.000815	CcSEcCtD
Emtricitabine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000799	0.000815	CcSEcCtD
Emtricitabine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000797	0.000812	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000794	0.000809	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000777	0.000792	CcSEcCtD
Emtricitabine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000761	0.000776	CcSEcCtD
Emtricitabine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000751	0.000766	CcSEcCtD
Emtricitabine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000744	0.000758	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000698	0.000711	CcSEcCtD
Emtricitabine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000697	0.000711	CcSEcCtD
Emtricitabine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000693	0.000706	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000688	0.000701	CcSEcCtD
Emtricitabine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000675	0.000687	CcSEcCtD
Emtricitabine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000665	0.000678	CcSEcCtD
Emtricitabine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000664	0.000677	CcSEcCtD
Emtricitabine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000661	0.000673	CcSEcCtD
Emtricitabine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000661	0.000673	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000627	0.000639	CcSEcCtD
Emtricitabine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000626	0.000638	CcSEcCtD
Emtricitabine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000609	0.00062	CcSEcCtD
Emtricitabine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000606	0.000617	CcSEcCtD
Emtricitabine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000606	0.000617	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000565	0.000575	CcSEcCtD
Emtricitabine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00055	0.00056	CcSEcCtD
Emtricitabine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000542	0.000552	CcSEcCtD
Emtricitabine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000524	0.000534	CcSEcCtD
Emtricitabine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000507	0.000516	CcSEcCtD
Emtricitabine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000487	0.000496	CcSEcCtD
Emtricitabine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000492	CcSEcCtD
Emtricitabine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000492	CcSEcCtD
Emtricitabine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00048	0.000489	CcSEcCtD
Emtricitabine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000455	0.000464	CcSEcCtD
